Roche Freedman LLP v. Jason Cyrulnik

District Court, S.D. New York·Decided March 28, 2023·No. 1:21-cv-01746·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ──────────────────────────────────── ROCHE FREEDMAN LLP, Plaintiff, 21-cv-1746 (JGK)

- against - MEMORANDUM OPINION & ORDER JASON CYRULNIK, Defendant. ──────────────────────────────────── JASON CYRULNIK, Counterclaim-Plaintiff,

- against -

ROCHE FREEDMAN LLP, ET AL., Counterclaim-Defendants. ──────────────────────────────────── JOHN G. KOELTL, District Judge: The plaintiff, Roche Freedman LLP (the “Firm”) brought this action for declaratory judgment, breach of fiduciary duty, and intentional interference with contract against Jason Cyrulnik, a founding partner of the Firm.1 Cyrulnik then brought a host of statutory and common-law counterclaims against the Firm and five of its then-attorneys -- Kyle Roche, Devin Freedman, Amos

1 When these motions to dismiss were briefed, this action was captioned Roche Cyrulnik Freedman LLP v. Jason Cyrulnik. On August 15, 2022, the Clerk of Court changed the caption to Roche Freedman LLP v. Jason Cyrulnik. ECF No. 201. “Roche Cyrulnik Freedman LLP” was then terminated as a party and replaced with “Roche Freedman LLP.” In the interest of clarity, this Memorandum Opinion & Order will refer to the plaintiff by the name listed on the caption: Roche Freedman LLP. This naming decision is not a judicial determination that Cyrulnik is no longer a partner in the Firm; he alleges that he is still a partner. See Answer & Counterclaims, ECF No. 72, ¶ 106 (“Cyrulnik remains a Founding Partner and Co-Chairperson of [Roche Cyrulnik Freedman LLP].”); see also ECF No. 277 (November 9, 2022 letter by Cyrulnik continuing to refer to the case as Roche Cyrulnik Freedman LLP v. Cyrulnik). Friedland, Nathan Holcomb, and Edward Normand (the “Individual Counterclaim-Defendants” and, with the Firm, the “Counterclaim- Defendants”) -- arising from what Cyrulnik alleges was his

wrongful removal from the Firm. See Answer & Counterclaims (“Counterclaims”), ECF No. 72, ¶¶ 103-174. The Individual Counterclaim-Defendants now move pursuant to Federal Rule of Civil Procedure 12(b)(6) to dismiss Cyrulnik’s counterclaims against them. ECF No. 102 (motion of Roche and Freedman); ECF No. 107 (motion of Friedland, Holcomb, and Normand). For the following reasons, the motions to dismiss are granted in part and denied in part. I. For purposes of this motion, the Court accepts as true the following allegations from Cyrulnik’s Counterclaims. In 2004, Cyrulnik graduated from law school and joined the

law firm Boies Schiller Flexner LLP (“BSF”). Counterclaims ¶ 20. Over the next fifteen years, Cyrulnik became an equity partner at BSF and built a substantial client base there. Id. ¶¶ 20-22. In summer 2019, Roche and Freedman, two more junior attorneys at BSF, left BSF to form Roche Freedman LLP, a law firm focusing on cryptocurrency and other specialized practice areas. Id. ¶¶ 3, 25. Among the Firm’s early clients was a technology startup (the “Startup”) that agreed to pay the Firm for its legal services with cryptocurrency known as “Tokens.” Id. ¶¶ 33, 50-55. Throughout summer and fall 2019, Roche Freedman LLP tried

to recruit Cyrulnik, who was also being recruited by several national law firms. Id. ¶¶ 3, 24, 28. In exchange for Cyrulnik’s agreement to leave BSF, Roche and Freedman promised him significant stakes in what they described as their high-upside contingency work and in certain assets they had secured. Id. ¶ 28. After extensive negotiations, Cyrulnik agreed to leave BSF to form the law firm Roche Cyrulnik Freedman LLP (“RCF”), a Florida limited liability partnership with offices in Miami, Florida and New York City. Id. ¶¶ 11, 29. On December 27, 2019, RCF’s six founding partners -- name partners Cyrulnik, Roche, and Freedman, together with Friedland, Holcomb, and Normand -- signed a Memorandum of Understanding to govern the partnership.

Id. ¶ 30; see also Counterclaims, Ex. A, ECF No. 72-1 (the “MOU”). The MOU’s “Compensation Model” set forth distribution methodologies for revenue earned through hourly and contingency matters. Counterclaims ¶ 31. Beyond compensation from these matters, the MOU also entitled Cyrulnik to 27% of the Firm’s equity, the largest share, plus 25% of a fixed allocation of the Tokens to be issued by the Startup. Id. ¶¶ 31, 33. Two provisions of the MOU governed the departure of a Founding Partner from the Firm. Id. ¶ 35. Under the first section, “Withdrawal from Firm,” a Founding Partner who withdrew from the Firm within 18 months of the Firm’s formation would be entitled only to compensation under the Firm’s Compensation

Model and would be required to return his equity “to the balance of the firm’s equity partners pro-rata.” MOU § VI(C) (the “Withdrawal Provision”); see also Counterclaims ¶ 35. The second section, “Partner Removal,” provided that a “Founding Partner cannot be removed without cause” and that, even if cause arose to remove a Founding Partner, that removal would require a two- thirds vote of the Firm’s equity partners. Counterclaims ¶ 36; MOU § VI(G) (the “Removal Provision”). In contrast to the Withdrawal Provision, the Removal Provision did not expressly provide that an involuntary removal would result in the forfeiture of any compensation, interests, or assets owed or allocated to a partner under the MOU. Counterclaims ¶ 36;

MOU § VI(G). A week after signing the MOU, on January 4, 2020, Roche, Cyrulnik, and Freedman entered into a separate agreement. Counterclaims ¶ 37; Counterclaims, Ex. B, ECF No. 72-2 (the “Side Letter”).2 In the Side Letter, Roche allegedly agreed to

2 The top of the Side Letter reads “Memorandum of Understanding January 4, 2019,” but the year appears to have been a typo. Cyrulnik alleges that the Side Letter was signed “in January 2020,” Counterclaims ¶ 37, the body of the Side Letter states that it “is dated and made effective as of 1/4/20,” and the signatures of Roche, Freedman, and Cyrulnik are dated January 27, 2020, January 21, 2020, and January 22, 2020, respectively, see Side Letter. pay Cyrulnik $850,000 for the right to be listed as the first named partner at RCF. Counterclaims ¶ 37; Side Letter. The Side Letter also provided that Cyrulnik would receive a 25% interest

in the Firm’s anticipated recovery in a major contingency matter not included in RCF’s Compensation Model. Counterclaims ¶ 37; Side Letter. Cyrulnik’s clients followed him from BSF to RCF, and he continued to grow his business in 2020. Counterclaims ¶ 40. That year, Cyrulnik allegedly generated more than 60% of the Firm’s revenue and about 70% of its profits. Id. Throughout 2020 and into January 2021, the name partners generally worked well together, although Cyrulnik raised concerns about Roche’s attitude toward client billings and Roche’s obligations as class counsel, as well as Freedman’s alleged efforts to exploit the Firm’s Compensation Model through referral fees and discounts.

Id. ¶¶ 45-48, 60. Then, in early 2021, the Tokens issued by the Startup increased more than 15 times in value. Id. ¶ 66. The value of the Firm’s Token rights increased to about $250 million, with Cyrulnik’s share peaking at over $60 million. Id. ¶¶ 66, 68. At this point, Cyrulnik alleges, his partners no longer needed the revenue from his client base to fund the Firm’s operations, and they schemed to remove him. -Se-e- -id-.- ¶¶ 5-6, 69. On February 10, 2021, Roche, Freedman, Normand, Holcomb, and Friedland convened a “secret meeting,” to which Cyrulnik and the Firm’s seventh equity partner, Paul Fattaruso -- allegedly the only partner at the Firm who worked regularly with Cyrulnik on the Firm’s core

matters -- were not invited. Id. ¶¶ 70, 71.

Free access — add to your briefcase to read the full text and ask questions with AI

Roche Freedman LLP v. Jason Cyrulnik, (S.D.N.Y. 2023).

Roche Freedman LLP v. Jason Cyrulnik (Roche Freedman LLP v. Jason Cyrulnik) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

McCarthy v. Dun & Bradstreet Corp.
482 F.3d 184 (Second Circuit, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
DiFolco v. MSNBC Cable L.L.C.
622 F.3d 104 (Second Circuit, 2010)
V.S. Ex Rel. T.S. v. Muhammad
595 F.3d 426 (Second Circuit, 2010)
Shephard v. Ouellete
854 So. 2d 251 (District Court of Appeal of Florida, 2003)
Condit v. Dunne
317 F. Supp. 2d 344 (S.D. New York, 2004)
Bristol-Myers Squibb Co. v. Matrix Laboratories Ltd.
655 F. App'x 9 (Second Circuit, 2016)
Fernandez v. Basil Yates, M.D., P.A.
145 So. 3d 141 (District Court of Appeal of Florida, 2014)
Chambers v. Time Warner, Inc.
282 F.3d 147 (Second Circuit, 2002)
Goldman v. Belden
754 F.2d 1059 (Second Circuit, 1985)